| OA19.03 | Transcriptional analysis of cervical cell populations reveals inflammatory signatures and differential epithelial keratinization associated with Depo-Provera use | Oral Abstract Session | Mucosal immunity |
| OA19.02 | Construction of a comprehensive bacterial genome catalogue for the female genital tract identifies hundreds of new species | Oral Abstract Session | Microbiome & STI: impact on prevention |
| OA19.01 | Impact of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomized placebo-controlled trial | Oral Abstract Session | Microbiome & STI: impact on prevention |
| OA18.05LB | Multivalent antigen presentation increases the antibody binding breadth and neutralizing potency upon the immunization with a self-assembling HIV env vaccine | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA18.04 | Heterologous prime boost immunisations with improved DNA, MVA and protein HIV-1 subtype C vaccines elicit Tier 2 neutralising antibodies in a Chinese rhesus monkey model | Oral Abstract Session | Preclinical studies for HIV prevention |
| OA18.03 | Alum-adjuvanted protein administered in combination with ALVAC-HIV downregulates early serum cytokine responses to the vaccine whereas MF59 enhances the early cytokine burst | Oral Abstract Session | Implementation science, including structural interventions, PrEP & VMMC |
| OA18.02 | Similar antibody responses to subtype C ALVAC-HIV/gp120 vaccine regimens using different adjuvants (MF59 vs. alum) but enhanced response rates and magnitude when ALVAC-HIV and gp120 were co-administered | Oral Abstract Session | Clinical trial results |
| OA18.01 | Early Vaccine-Induced V1V2 Antibody Responses in Four Pox-Protein Public Private Partnership (P5) HIV Vaccine Trials | Oral Abstract Session | Humoral immunity |
| OA17.05 | Redefining ownership: the mismatch between female sex workers' research priorities and the field in Kenya | Oral Abstract Session | Community engagement in prevention research |
| OA17.04 | Examining systemic racism in 'empowerment-based' HIV prevention research: reflections of a US-France research partnership | Oral Abstract Session | Community engagement in prevention research |